Anaphylaxis

Anaphylaxis

Anaphylactic shock

anaphylactic shock, general malaise

Rare hypersensitivity Very rare anaphylactic shock

Serious allergic reactions, anaphylactic shock, anaphylaxis

Immune system disorders Uncommon hypersensitivity reactions such as generalised skin reactions, flushing, oedema (face oedema, oedema peripheral and ansarca), hypertension, arthralgia and pruritis Very rare allergic and anaphylactoid like reactions such as tachycardia, hypotension, circulatory collapse and anaphylactic shock

thrombocytopenia

Anaphylactic reaction, anaphylactic shock including fatal shock, hypersensitivity, urticaria

Very rare anaphylactic shock (including fatal hypersensitivity) Metabolism and nutrition disorders

Immune system disorders Uncommon hypersensitivity reactions such as generalised skin reactions, flushing, oedema (face oedema, oedema peripheral and ansarca), hypertension, arthralgia and pruritis Very rare allergic and anaphylactoid like reactions such as tachycardia, hypotension, circulatory collapse and anaphylactic shock

severe allergic reaction (anaphylactic reaction, anaphylactic shock, serum sickness) which can

20 cases of bronchospasm, angioneurotic oedema and anaphylactic shock.

Angioedema, bronchial Anaphylactic shock, constriction, fever. impotence and general malaise

severe allergic reactions (anaphylactic reaction or anaphylactic shock, which can be fatal

Anaphylactic shock, impotence and general malaise

Hypersensitivity reactions including anaphylaxis, bronchospasm, angioedema, pruritus, rash, and urticaria

Metabolism and nutrition disorders Uncommon hyperkalaemia

anaphylactic reaction, anaphylactic shock, hypersensitivity reactions (angioedema, dyspnoea, urticaria, rash, pruritic rash)

au difficulties in breathing (bronchospasm) swelling of the tongue or throat anaphylactic shock (a very severe type of allergic response)

Rectal bleeding Diverticulitis Pancreatitis Bullous eruptions Hypersensitivity (e. g. pruritus, rash, urticaria, angioedema, bronchospasm and anaphylaxis) Cholelithiasis Hepatitis that may be serious

(angiooedema), severe allergic reaction (anaphylactic shock) which can be life threatening (see Section 2

AN 69) membrane and treated concomitantly with an ACE inhibitor, therefore, this combination must be avoided.

3 Serious immediate hypersensitivity reactions (eg anaphylaxis, anaphylactic shock and anaphylactoid reactions, hypotension and angioedema) have been reported following the administration of Luminity.

Very rare serious allergic type reactions, such as bronchospasm, swelling of the tongue and throat, and in isolated cases, anaphylaxis.

Hypersensitivity reactions including rare cases of bronchoconstriction, urticaria and angioedema, and very rare cases of anaphylactic reaction shock

Severe anaphylactic and other hypersensitivity reactions, including anaphylactic shock and angioedema, have been reported following MabCampath administration.

Life threatening reactions, including very severe generalised allergic reactions and anaphylactic shock, have been reported in some patients.

Pancytopenia, Bone marrow depression, Anaphylactic shock, Psychotic reactions, Migraine, Olfactory nerve disorders, Hearing impaired, Vasculitis, Pancreatitis, Liver necrosis, Petechiae, Tendon rupture

Severe acute hypersensitivity reactions and anaphylactic shock require immediate discontinuation of the administration of ceftriaxon and the initiation of appropriate emergency measures.

Rare severe allergic reactions (anaphylaxis) have been associated with the administration of human albumin products.

Anaphylaxis, including anaphylactic shock with fatal outcome has been reported very rarely in post marketing experience (see section 4.8).

Daronrix should not be given to patients who have had an anaphylactic reaction (severe allergic reaction) to any of the components of the vaccine, or to any substances found at trace levels in the vaccine, such as eggs, chicken protein or gentamicin sulphate (an antibiotic).

Post marketing Rare cases suggestive of hypersensitivity, which could include skin erythema, bradycardia, hypotension or anaphylactic shock have been reported following the injection of SonoVue.

Although the underlying mechanism has not been identified, some of these reactions may be anaphylactoid anaphylactic in nature and may include symptoms such as bronchospasm, urticaria, hypotension, loss of consciousness or shock.

These reactions include anaphylaxis, angioedema, and exfoliative skin conditions including Stevens Johnson syndrome.

Skin and subcutaneous tissue disorders pruritus, rash, urticaria Immune system disorders hypersensitivity reactions including anaphylactic reactions

Acute hypersensitivity reactions including angioedema, anaphylaxis and anaphylactic reactions including anaphylactic shock, idiopathic thrombocytopenic purpura, thrombotic thrombocytopenic purpura, systemic lupus erythematosus, vasculitis, arthritis rheumatoid and arthritis rheumatoid aggravated

Remicade should not be used in patients who have experienced hypersensitivity (allergy) to infliximab in the past, or who are hypersensitive (allergic) to mouse proteins or any of the other ingredients of Remicade.

Rarely human normal immunoglobulins may cause a sudden fall in blood pressure and, in isolated cases, anaphylactic shock, even when the patient has shown no hypersensitivity to previous administration.

weak quick pulse, clammy skin, dizziness as a result of severe allergy to this medicine (anaphylactic shock), itching rash, fever, joint swellings, muscle pains, rash (symptoms similar to those occurring in a disease called serum sickness)

Respiratory, thoracic and mediastinal disorders

Shock

rash

hypokalaemia, hypomagnesaemia, hypocalcaemia